Related Experiment Video
Updated: Aug 19, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
A Recipe for Delirium: Community-Acquired Pneumonia and Sickle Cell Anemia With Moyamoya Disease
Franklin Alier1, Lyanne Santana2, Waiz Wasey3
1Psychiatry, Southern Illinois University School of Medicine, Springfield, USA.
Abstract:
Moyamoya disease (MMD) is a rare, progressive cerebrovascular disorder that occurs when the major arteries supplying the brain become narrowed or obstructed. Because of this, small and delicate collateral vessels develop to compensate for the decrease in blood flow. Unfortunately, these vessels are insufficient to meet the brain's metabolic demands. Though initially described in Japan, MMD occurs in a variety of ethnicities around the world. The clinical manifestations of the disease can be devastating, with patients often presenting with symptoms of a stroke or transient ischemic attack. The long history of insults and chronic changes to the brain makes these individuals susceptible to alterations in their mental status. We describe a case of a young African American female with a history of sickle cell anemia (SCA) and undiagnosed MMD who presented to the emergency department with community-acquired pneumonia (CAP). In addition to her medical derangements, she also presented with paranoia, delusional guilt, and refusal to speak.
Insights
Moyamoya disease (MMD) is a rare cerebrovascular disorder causing brain artery obstruction. This case highlights MMD
Area of Science:
- Neuroscience
- Vascular Neurology
- Genetics
Background:
- Moyamoya disease (MMD) is a rare, progressive cerebrovascular disorder characterized by stenosis of the terminal internal carotid arteries and the development of abnormal collateral vessels.
- MMD can affect individuals of various ethnicities worldwide, often presenting with stroke or transient ischemic attack symptoms.
- Chronic cerebrovascular changes in MMD can lead to neurological and cognitive deficits.
Observation:
- A young African American female with a history of sickle cell anemia (SCA) presented with community-acquired pneumonia (CAP).
- The patient exhibited psychiatric symptoms including paranoia, delusional guilt, and mutism.
- Undiagnosed Moyamoya disease was identified as a contributing factor to her presentation.
Findings:
- The co-occurrence of Moyamoya disease and sickle cell anemia presents unique diagnostic and management challenges.
- Cerebrovascular compromise in MMD can exacerbate neurological symptoms, including psychiatric manifestations.
- Prompt diagnosis and management of MMD are crucial in patients with complex medical histories.
Implications:
- This case underscores the importance of considering MMD in patients with unexplained neurological and psychiatric symptoms, particularly those with underlying conditions like SCA.
- Early recognition and treatment of MMD can potentially prevent severe neurological sequelae.
- Further research is needed to elucidate the interplay between MMD, SCA, and psychiatric comorbidities.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: